Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ACASTI-PHARMA-INC-24446197/news/Acasti-Successfully-Submits-Pivotal-GTX-104-Phase-3-Safety-Study-Protocol-with-FDA-and-Implements-St-43775456/?utm_source=whatsapp&utm_medium=social&utm_campaign=share